SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group shares are seeing high volatility as the community reacts to a controversial speech from the former president regarding election integrity and the company's new initiative to sell premium, real-time access to his social media posts. Investors and detractors alike are intensely debating the platform's monetization strategy and the broader implications of these political developments on the stock's future performance.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as investors weigh the impact of rising geopolitical tensions and uncertainty in AI infrastructure spending against strong dip-buying activity. Market participants are intensely focused on a tug-of-war between institutional selling and retail-driven momentum, with active debate surrounding potential reversals and whether current price action represents a temporary relief bounce or a structural bottom.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending as investors weigh high short interest against strong institutional accumulation and recent enterprise growth milestones. The community remains deeply divided, with bulls pointing to a potential squeeze setup driven by loaded call options and merger progress, while bears continue to highlight concerns over cash burn and ongoing dilution.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing a sharp selloff as investors react to conservative revenue guidance and a pivot toward less transparent reporting, fueling concerns about the company's long-term growth trajectory. While the community remains deeply divided, many are debating whether the price drop presents a buying opportunity based on strong cash flow and share buybacks, or if the stock is trapped in a structural downtrend due to increased competition and shifting content quality.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is experiencing significant volatility following an earnings report that featured a strong top-and-bottom-line beat but was met with investor concern regarding slowing procedure growth and cautious guidance. The community is actively debating whether this pullback represents a buying opportunity for a long-term compounder at a rare valuation discount, or if competitive pressures and macroeconomic headwinds signal a deeper shift in the robotic surgery landscape.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility and a sharp intraday reversal, with the community actively debating whether this movement represents a sustainable bottom or another temporary bear trap. Traders are heavily focused on the rapid shift from fear to FOMO, with much of the discussion centered on the stock's role in AI infrastructure and the ongoing battle between bears betting on a correction and bulls aggressively buying the dip.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing a significant upward trend driven by strong retail momentum, improved sentiment surrounding its international growth, and a tactical rotation into consumer staples. The community is actively discussing the stock's potential for a short squeeze given its high short interest, while long-term investors highlight the brand's expanded distribution ecosystem and the successful integration of Alani Nu as key growth drivers.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors debate the impact of the company's $10 billion investment in Alphabet and its acquisition of Taylor Morrison, highlighting a pivot toward AI infrastructure and housing recovery. The community remains sharply divided between those viewing the cash-rich conglomerate as a defensive anchor for uncertain markets and those frustrated by its recent underperformance compared to high-growth tech.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors react to a significant sell-off alongside news of a $775M non-dilutive debt facility aimed at expanding its AI infrastructure. The community is actively debating whether the price drop represents a prime accumulation opportunity for long-term AI play or if broader sector rotation and competition concerns suggest further downside.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant selling pressure as investors grapple with concerns over share dilution, ongoing regulatory scrutiny, and a broader rotation out of the AI hardware sector. While the community is sharply divided between those calling the stock fundamentally undervalued based on growth and order backlogs, and skeptics emphasizing corporate governance risks and financial transparency, the stock's recent volatility has triggered intense debate over its near-term recovery potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SRZN next week is the OIS event in Canada. Surrozen will present there. This time they not only mentioned the VEGF combination drugs but also an asset against GA. The biggest drugs against GA are complement inhibitors. Biogen acquired Appelis and their complement drug earlier this year and Astellas acquired another complement drug with the acquisition of Iveric Bio in 2023.

StockTwits Web

Surrozen Inc

 next week is the OIS event in Canada. Surrozen will present there. This time they not only mentioned the VEGF combination drugs but also an asset against GA. The biggest drugs against GA are complement inhibitors. Biogen acquired Appelis and their complement drug earlier this year and Astellas acquired another complement drug with the acquisition of Iveric Bio in 2023.

Peter

Merck will also present at the same event with Erin Henry a person that has a lot of experience with complement drug development from her past at Genentech, Iveric Bio, Astellas and NGM Bio.

WNT drugs could work in combination with complement drugs against GA. Since they are the standard of care Surrozen probably already tested this in preclinical trials and knows if that is the case or not. Surrozen could also make a combination molecule that combines WNT activation with complement inhibition. Regeneron&#39;s only ophthalmology pipeline asset right now is also a complement drug so they could also be very interested in a potential combination of WNT plus complement drug.

WNT drugs could work in combination with complement drugs against GA. Since they are the standard of care Surrozen probably already tested this in preclinical trials and knows if that is the case or not. Surrozen could also make a combination molecule that combines WNT activation with complement inhibition. Regeneron's only ophthalmology pipeline asset right now is also a complement drug so they could also be very interested in a potential combination of WNT plus complement drug.

Some interesting connections here. NGM Bio was/is a TCG company and they hired Erin Henry for the development of NGM621 which was an anti C3 drug so a complement drug. It was developed in cooperation with Merck but then it failed. Erin moved on to Iveric Bio/Astellas and then Merck. She could still have connections to TCG/Surrozen which is now developing WNT drugs against GA and Merck still doesn&#39;t have drugs against GA on their pipeline.

Some interesting connections here. NGM Bio was/is a TCG company and they hired Erin Henry for the development of NGM621 which was an anti C3 drug so a complement drug. It was developed in cooperation with Merck but then it failed. Erin moved on to Iveric Bio/Astellas and then Merck. She could still have connections to TCG/Surrozen which is now developing WNT drugs against GA and Merck still doesn't have drugs against GA on their pipeline.

More connections. Erin Henry was hired by NGM Bio where David Woodhouse was the CEO. He is chairman of the board at Surrozen. Charles Wykoff was also involved in NGM Bio and now on the advisory board of Surrozen.